Overview


According to FutureWise analysis the market for apheresis equipment in 2023 is US$ 2.96 billion, and is expected to reach US$ 6.89 billion by 2031 at a CAGR of 11.20%.

Apheresis equipment is a medical device used in a procedure called apheresis, which is a medical treatment that involves removing certain components of a patient's blood and then returning the remaining blood components back to the patient's circulation. The word "apheresis" comes from the Greek word "aphaeresis," which means "to take away" or "to separate." Apheresis equipment typically consists of a machine with specialized tubing, a centrifuge, and filters that separate and collect specific blood components. The machine is operated by trained healthcare professionals.

Apheresis equipment is important for performing safe and efficient apheresis procedures. Disposable apheresis kits are essential for maintaining sterility and preventing contamination during the procedure. These kits contain all the necessary single-use components required for performing an apheresis procedure. These kits include sterile tubing sets, needles, collection bags, anticoagulants, and other disposable materials required for a safe and effective apheresis session. Whereas apheresis machines automate the process, providing precise control and safety. It is equipped with pumps, a centrifuge, filters, sensors, and a control system to regulate blood flow, separate the desired components, and return the rest to the donor or patient. Apheresis machines can be of various types, including centrifugal and membrane-based systems. Also, they play a vital role in transfusion medicine, hematology, and renal diseases.

FutureWise Market Research has published a report that provides an insightful analysis apheresis equipment market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts apheresis equipment market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Terumo BCT
  • Hemacare
  • Fenwal
  • Haemonetics
  • Asahi Kasei Kuraray Medical
  • B. Braun
  • Fresenius
  • Therakos
  • Cerus Corporation
  • Baxter International Inc.
  • Kaneka Corporation
  • Kawasumi Laboratories

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Apheresis Equipment Market:

  • In June 2022, Terumo Blood and Cell Technologies announced that NHS England had selected their Spectra Optia Apheresis System for the automated red blood cell exchange (RBCX) method to address sickle cell disease under the NHS MedTech Funding Mandate (MTFM). This decision will lead to expanding Spectra Optia's implementation in hospitals across England. This apheresis equipment enhances accessibility to this transformative treatment for individuals with sickle cell disease.

The growing incidence of blood-related diseases, such as kidney diseases, various forms of cancer, metabolic disorders, and neurological conditions, is poised to be a major driver propelling the apheresis equipment market expansion during the projection period. With an aging population and changing lifestyles contributing to the surge in these conditions, the demand for advanced apheresis equipment is set to increase, as these technologies play an important role in managing and treating such disorders effectively. This rising demand underscores a crucial need for sophisticated apheresis solutions, thus fueling market growth. Also, the indispensability of apheresis in collecting blood components, like platelets, plasma, and white blood cells, underpins its critical role in modern healthcare. These components are integral in many medical interventions, from transfusions for patients with compromised immune systems to life-saving treatments for those battling cancer or experiencing complex surgeries. In critical care settings, where every minute is essential, the capability to swiftly and precisely obtain these specialized components could make a real difference in patient outcomes. However, the investment and ongoing maintenance expenses associated with apheresis equipment may pose a significant hurdle, especially for smaller healthcare facilities and those operating in resource-constrained environments. For these commodities, allocating a significant amount of their budget to develop and upkeep apheresis technology may divert resources from other crucial healthcare priorities. This financial constraint could limit their ability to offer apheresis procedures, potentially depriving patients in these settings of access to this advanced therapeutic alternative. Thus hindering the target market.

By Product Type

  • Disposable apheresis kits
  • Apheresis machine

By Application Type

  • Renal Diseases
  • Hematology
  • Neurology
  • Others

By Procedure

  • Plasmapheresis
  • LDL-apheresis
  • Plateletpheresis
  • Leukapheresis
  • Photopheresis
  • Erythrocytapheresis
  • Others

By Technology

  • Membrane Filtration
  • Centrifugation

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is primarily attributed to the increasing number of platelet donors, rising incidence of blood-related diseases such as kidney disease, cancer, metabolic disease, and neurological disorders, R&D investments by biopharmaceutical companies, growing demand for the other components of the blood, and well-established healthcare infrastructure is expected to boost the market expansion in the region. Furthermore, highly skilled professionals to operate the equipment, the presence of established market players manufacturing apheresis equipment, an increase in geriatric population, and improvement in the reimbursement policies are factors driving the apheresis equipment market over the forecast period in the area.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Apheresis Equipment Market By Product Type, By Application Type, By Procedure, By Technology and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Apheresis Equipment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Apheresis Equipment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Apheresis Equipment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Apheresis Equipment Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Disposable apheresis kits
        2. Apheresis machine

  • 8.   Apheresis Equipment Market, By Application Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Renal Diseases
        2. Hematology
        3. Neurology
        4. Others

  • 9.   Apheresis Equipment Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Plasmapheresis
        2. LDL-apheresis
        3. Plateletpheresis
        4. Leukapheresis
        5. Photopheresis
        6. Erythrocytapheresis
        7. Others

  • 10.   Apheresis Equipment Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Membrane Filtration
        2. Centrifugation

  • 11.   North America Apheresis Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Apheresis Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Apheresis Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Apheresis Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Terumo BCT
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Hemacare
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Fenwal
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Haemonetics
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Asahi Kasei Kuraray Medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B. Braun
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Fresenius
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Therakos
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Cerus Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Baxter International Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Kaneka Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Kawasumi Laboratories
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients